RCE — Recce Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Recce Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 June 30th	R2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	Interim Report	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.403	2.68	20.9	11.6	1.61
Net Total Accounts Receivable
Net Total Receivables	0.037	0.041	0.245	0.182	0.091
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.453	2.74	21.2	12.2	1.95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.469	0.505	0.501	0.439	0.608
Other Long Term Assets
Total Assets	0.922	3.24	21.7	12.6	2.56
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.27	0.885	1.08	2.45	4.85
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.33	0.932	1.18	2.56	5.14
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	-0.406	2.31	20.5	10.1	-2.59
Total Liabilities & Shareholders' Equity	0.922	3.24	21.7	12.6	2.56
Total Common Shares Outstanding